DXB 2.30% 44.5¢ dimerix limited

DXB Chart, page-591

  1. 1,544 Posts.
    lightbulb Created with Sketch. 385
    Partnering is a step that can help open up resources, is usually a win win for both companies and can help lead into M&A talks down the track. Often becomes a sign of confidence to buyers that see the partnership as a deriding event especially when they’ve not been able to put in same amount of DYOR as a biotech.

    This slide below is a good snapshot of some types of alliances/partnerships.

    Understand what you mean about waiting for more results to negotiate from position of strength, but might be plenty of data sharing going on behind the scenes now. For buyout we want as much data but a partnership might allow us access to that company’s resources like drug reps and sales marketing teams who have relationships with hospitals and insurance companies.

    https://hotcopper.com.au/data/attachments/5870/5870044-b50acbcf5ce0f6b270296fdbbb77b2d6.jpg

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
44.5¢
Change
0.010(2.30%)
Mkt cap ! $245.0M
Open High Low Value Volume
44.5¢ 46.0¢ 44.0¢ $882.2K 1.961M

Buyers (Bids)

No. Vol. Price($)
3 55281 44.5¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 27933 2
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.